Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More


Learn what's happening in the world of Dohmen and our clients
June 01, 2016

Dohmen showcases orphan drug and rare disease expertise at BIO International Convention

Dohmen Life Science Services experts will join more than 15,000 biotech and pharma leaders at the BIO International Convention in San Francisco, CA, June 7-9.
learn more
May 11, 2016

Colorado BioScience Association taps Dohmen’s Terry Dagnon to join Board of Directors

The Colorado BioScience Association (CBSA) has asked Terry Dagnon, M.S., DLSS Senior Vice President of Operations, to join its Board of Directors.
learn more
May 02, 2016

Growth in life sciences and health industry fuels Dohmen’s expansion

Dohmen announces purchase of 215 N. Water St., five-story building in Third Ward; corporate team to relocate.
learn more
April 18, 2016

Dohmen joins rare disease experts at the World Orphan Drug Congress

More than 600 leaders in the rare disease community head to Washington, DC this week for World Orphan Drug Congress (WODC) USA, the largest orphan drug industry event in the world.
learn more
April 12, 2016

Dohmen earns Milwaukee-area recognition for Human Resources leadership

Dohmen is excited to share that its Human Resources Department is among the 10 winners selected for the Milwaukee Business Journal’s 2016 HR Awards.
learn more
March 21, 2016

Dohmen featured in pharmaceutical magazine

Dohmen Life Science Services is featured inside the latest issue of Pharmaceutical Commerce with commentary from Dr. Eric Floyd, Chief Science Officer.
learn more
March 18, 2016

Dohmen heads to Florida for DIA Medical & Scientific Communications Forum

This annual forum features education and networking opportunities tailored to professionals in medical communication, medical science, and writing for the biopharmaceutical industry.
learn more
March 11, 2016

Dohmen raises $5,000 for rare disease awareness

Dohmen employees rallied together for Rare Disease Day and donated over $5,000 for the rare disease community, including organizations such as Global Genes and NORD.
learn more